Paclitaxel-etoposide-carboplatin/cisplatin versus etoposide-carboplatin/cisplatin as first-line treatment for combined small-cell lung cancer: a retrospective analysis of 62 cases.
about
Paclitaxel-etoposide-carboplatin/cisplatin versus etoposide-carboplatin/cisplatin as first-line treatment for combined small-cell lung cancer: a retrospective analysis of 62 cases.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Paclitaxel-etoposide-carboplat ...... spective analysis of 62 cases.
@ast
Paclitaxel-etoposide-carboplat ...... spective analysis of 62 cases.
@en
type
label
Paclitaxel-etoposide-carboplat ...... spective analysis of 62 cases.
@ast
Paclitaxel-etoposide-carboplat ...... spective analysis of 62 cases.
@en
prefLabel
Paclitaxel-etoposide-carboplat ...... spective analysis of 62 cases.
@ast
Paclitaxel-etoposide-carboplat ...... spective analysis of 62 cases.
@en
P2093
P2860
P1476
Paclitaxel-etoposide-carboplat ...... spective analysis of 62 cases.
@en
P2093
Deng-Xia Yang
Xin-Yue Wang
Zhu-Jun Liu
P2860
P304
P356
10.7497/J.ISSN.2095-3941.2015.0012
P577
2015-06-01T00:00:00Z